Literature DB >> 30371673

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture.

Andrea Introini1, Christophe Vanpouille2, Wendy Fitzgerald2, Kristina Broliden3, Leonid Margolis2.   

Abstract

Histocultures allow studying intercellular interactions within human tissues, and they can be employed to model host-pathogen interactions under controlled laboratory conditions. Ex vivo infection of human tissues with human immunodeficiency virus (HIV), among other viruses, has been successfully used to investigate early disease pathogenesis, as well as a platform to test the efficacy and toxicity of antiviral drugs. In the present protocol, we explain how to process and infect with HIV-1 tissue explants from human tonsils and cervical mucosae, and maintain them in culture on top of gelatin sponges at the liquid-air interface for about two weeks. This non-polarized culture setting maximizes access to nutrients in culture medium and oxygen, although progressive loss of tissue integrity and functional architectures remains its main limitation. This method allows monitoring HIV-1 replication and pathogenesis using several techniques, including immunoassays, qPCR, and flow cytometry. Of importance, the physiologic variability between tissue donors, as well as between explants from different areas of the same specimen, may significantly affect experimental results. To ensure result reproducibility, it is critical to use an adequate number of explants, technical replicates, and donor-matched control conditions to normalize the results of the experimental treatments when compiling data from multiple experiments (i.e., conducted using tissue from different donors) for statistical analysis.

Entities:  

Mesh:

Year:  2018        PMID: 30371673      PMCID: PMC6235519          DOI: 10.3791/57013

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  25 in total

1.  Sustained secretion of immunoglobulin by long-lived human tonsil plasma cells.

Authors:  Jacob M van Laar; Marc Melchers; Y K Onno Teng; Boris van der Zouwen; Rozbeh Mohammadi; Randy Fischer; Leonid Margolis; Wendy Fitzgerald; Jean-Charles Grivel; Ferdinand C Breedveld; Peter E Lipsky; Amrie C Grammer
Journal:  Am J Pathol       Date:  2007-08-09       Impact factor: 4.307

2.  Suppression of CCR5- but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6.

Authors:  J C Grivel; Y Ito; G Fagà; F Santoro; F Shaheen; M S Malnati; W Fitzgerald; P Lusso; L Margolis
Journal:  Nat Med       Date:  2001-11       Impact factor: 53.440

3.  Within 1 h, HIV-1 uses viral synapses to enter efficiently the inner, but not outer, foreskin mucosa and engages Langerhans-T cell conjugates.

Authors:  Y Ganor; Z Zhou; D Tudor; A Schmitt; M-C Vacher-Lavenu; L Gibault; N Thiounn; J Tomasini; J-P Wolf; M Bomsel
Journal:  Mucosal Immunol       Date:  2010-06-23       Impact factor: 7.313

4.  Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone.

Authors:  Jeffrey Pudney; Alison J Quayle; Deborah J Anderson
Journal:  Biol Reprod       Date:  2005-08-10       Impact factor: 4.285

5.  A common anti-cytomegalovirus drug, ganciclovir, inhibits HIV-1 replication in human tissues ex vivo.

Authors:  Christophe Vanpouille; Jean A Bernatchez; Andrea Lisco; Anush Arakelyan; Elisa Saba; Matthias Götte; Leonid Margolis
Journal:  AIDS       Date:  2017-07-17       Impact factor: 4.177

6.  Preclinical testing of candidate topical microbicides for anti-human immunodeficiency virus type 1 activity and tissue toxicity in a human cervical explant culture.

Authors:  James E Cummins; Jeannette Guarner; Lisa Flowers; Patricia C Guenthner; Jeanine Bartlett; Timothy Morken; Lisa A Grohskopf; Lynn Paxton; Charlene S Dezzutti
Journal:  Antimicrob Agents Chemother       Date:  2007-03-12       Impact factor: 5.191

7.  Evidence for the HIV-1 phenotype switch as a causal factor in acquired immunodeficiency.

Authors:  S Glushakova; J C Grivel; W Fitzgerald; A Sylwester; J Zimmerberg; L B Margolis
Journal:  Nat Med       Date:  1998-03       Impact factor: 53.440

Review 8.  The lymph node in HIV pathogenesis.

Authors:  Michael M Lederman; Leonid Margolis
Journal:  Semin Immunol       Date:  2008-07-14       Impact factor: 11.130

9.  Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection.

Authors:  Brandon F Keele; Elena E Giorgi; Jesus F Salazar-Gonzalez; Julie M Decker; Kimmy T Pham; Maria G Salazar; Chuanxi Sun; Truman Grayson; Shuyi Wang; Hui Li; Xiping Wei; Chunlai Jiang; Jennifer L Kirchherr; Feng Gao; Jeffery A Anderson; Li-Hua Ping; Ronald Swanstrom; Georgia D Tomaras; William A Blattner; Paul A Goepfert; J Michael Kilby; Michael S Saag; Eric L Delwart; Michael P Busch; Myron S Cohen; David C Montefiori; Barton F Haynes; Brian Gaschen; Gayathri S Athreya; Ha Y Lee; Natasha Wood; Cathal Seoighe; Alan S Perelson; Tanmoy Bhattacharya; Bette T Korber; Beatrice H Hahn; George M Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-19       Impact factor: 11.205

10.  R5 HIV-1 envelope attracts dendritic cells to cross the human intestinal epithelium and sample luminal virions via engagement of the CCR5.

Authors:  Mariangela Cavarelli; Chiara Foglieni; Maria Rescigno; Gabriella Scarlatti
Journal:  EMBO Mol Med       Date:  2013-04-22       Impact factor: 12.137

View more
  4 in total

1.  Mechanisms of residual immune activation in HIV-1-infected human lymphoid tissue ex vivo.

Authors:  Vincenzo Mercurio; Wendy Fitzgerald; Christophe Vanpouille; Ivan Molodtsov; Leonid Margolis
Journal:  AIDS       Date:  2021-07-01       Impact factor: 4.632

2.  An ex vivo model of medical device-mediated bacterial skin translocation.

Authors:  Hao Wang; Anant Agrawal; Yi Wang; David W Crawford; Zachary D Siler; Marnie L Peterson; Ricky T Woofter; Mohamed Labib; Hainsworth Y Shin; Andrew P Baumann; K Scott Phillips
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.996

3.  The Progestin Medroxyprogesterone Acetate Affects HIV-1 Production in Human Lymphoid Tissue Explants in a Dose-Dependent and Glucocorticoid-like Fashion.

Authors:  Christophe Vanpouille; Gökçe Günaydın; Mattias Jangard; Mario Clerici; Leonid Margolis; Kristina Broliden; Andrea Introini
Journal:  Viruses       Date:  2021-11-18       Impact factor: 5.048

4.  Complex human adenoid tissue-based ex vivo culture systems reveal anti-inflammatory drug effects on germinal center T and B cells.

Authors:  Angelika Schmidt; Johanna E Huber; Özen Sercan Alp; Robert Gürkov; Christoph A Reichel; Matthias Herrmann; Oliver T Keppler; Thomas Leeuw; Dirk Baumjohann
Journal:  EBioMedicine       Date:  2020-02-27       Impact factor: 8.143

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.